FDA-issued sodium targets yield no apparent impact
In 2021, the U.S. Food and Drug Administration (FDA) issued Phase I voluntary sodium reduction targets to encourage manufacturers to lower the amount of sodium in packaged food products by 2024. The targets appear to have had minimal impact, according to a study comparing the sod